PAK protein kinase modulator (Turning Point Therapeutics)

N/A

Report date: 2025/01/26 15:52:28
NME

Base Information

Drug NamePAK protein kinase modulator (Turning Point Therapeutics)
Drug Alias NamePAK protein kinase modulator (Bristol Myers Squibb)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionP21-activated kinases modulators
TargetsP21-activated kinases
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTurning Point Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesBristol-Myers Squibb Company
Inactive CompaniesTurning Point Therapeutics Inc
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A